Scarica l'app Stockscreener
240.08
0.81%
-1.97
Pre-mercato:
239.66
-0.42
-0.17%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DHR Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$242.05
Aprire:
$242.33
Volume 24 ore:
2.95M
Relative Volume:
0.84
Capitalizzazione di mercato:
$169.58B
Reddito:
$24.27B
Utile/perdita netta:
$3.50B
Rapporto P/E:
49.41
EPS:
4.8589
Flusso di cassa netto:
$5.02B
1 W Prestazione:
+0.08%
1M Prestazione:
+5.29%
6M Prestazione:
+26.42%
1 anno Prestazione:
-1.68%
Intervallo 1D:
$239.49
$242.80
Intervallo di 1 settimana:
$231.10
$242.80
Portata 52W:
$171.00
$258.23
Danaher Corp Stock (DHR) Company Profile
Nome
Danaher Corp
Settore
Industria
Telefono
(202) 828-0850
Indirizzo
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Confronta DHR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
240.08 | 170.97B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
TMO
Thermo Fisher Scientific Inc
|
639.45 | 239.06B | 43.74B | 6.58B | 6.11B | 17.31 |
|
IDXX
Idexx Laboratories Inc
|
691.05 | 55.61B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
239.05 | 41.11B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
138.63 | 39.62B | 6.95B | 1.30B | 1.15B | 4.5696 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-03-14 | Aggiornamento | Stifel | Hold → Buy |
| 2025-02-03 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-31 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Iniziato | HSBC Securities | Hold |
| 2023-12-13 | Ripresa | Wolfe Research | Peer Perform |
| 2023-12-07 | Downgrade | Goldman | Buy → Neutral |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-01 | Iniziato | SVB Securities | Outperform |
| 2023-04-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-10-24 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-08-17 | Ripresa | Bernstein | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-06-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Iniziato | Bernstein | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-10 | Reiterato | BofA Securities | Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-23 | Reiterato | Goldman | Buy |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-04-07 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-03 | Ripresa | Barclays | Overweight |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Ripresa | Stifel | Hold |
| 2019-10-28 | Reiterato | Needham | Buy |
| 2019-10-14 | Ripresa | Credit Suisse | Outperform |
| 2019-07-19 | Reiterato | Needham | Buy |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-04-17 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2019-02-25 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-03 | Iniziato | Needham | Buy |
| 2018-04-20 | Reiterato | Stifel | Buy |
Mostra tutto
Danaher Corp Borsa (DHR) Ultime notizie
iA Global Asset Management Inc. Sells 41,851 Shares of Danaher Corporation $DHR - MarketBeat
Anatomic Pathology Market Research: Global and Regional Insights, Competition, Forecast and Opportunities, 2025-2033 | Astute Analytica - GlobeNewswire Inc.
Danaher Corporation $DHR Shares Sold by Mountain Pacific Investment Advisers LLC - MarketBeat
The Truth About Danaher Corp: Why Wall Street Quietly Can’t Stop Buying - AD HOC NEWS
Danaher (DHR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Finviz
Danaher (NYSE:DHR) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says - MarketBeat
How Slowing Organic Growth And Margin Pressure At Danaher (DHR) Has Changed Its Investment Story - simplywall.st
Stock Yards Bank & Trust Co. Has $7.06 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Has $174.22 Million Position in Danaher Corporation $DHR - MarketBeat
Danaher (DHR) Valuation Check After Recent Share Momentum And Premium P/E Multiple - Yahoo Finance
Why Danaher (DHR) Price Target Reset Is Shaping A New Story For Investors - Yahoo Finance
United States Slide Stainer Market Insights and Competitive - openPR.com
The Truth About Fortive Corp: Is This Quiet Tech Giant Your Next Power Play? - AD HOC NEWS
Agilent and Danaher Eye Qiagen Acquisition as Shares Surge 19% - Intellectia AI
Danaher Corporation $DHR Holdings Trimmed by Fisher Funds Management LTD - MarketBeat
3 Reasons to Avoid DHR and 1 Stock to Buy Instead - Finviz
Published on: 2026-01-20 12:41:03 - baoquankhu1.vn
Massachusetts Financial Services Co. MA Sells 136,576 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Holdings Lifted by Allstate Corp - MarketBeat
3 Reasons DHR is Risky and 1 Stock to Buy Instead - Finviz
5,447 Shares in Danaher Corporation $DHR Acquired by Tred Avon Family Wealth LLC - MarketBeat
Rep. Julie Johnson Sells Danaher Corporation (NYSE:DHR) Stock - MarketBeat
QRG Capital Management Inc. Trims Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (DHR) Maintains Buy Rating as Analysts See Upside in 2026 - Finviz
Q3 Rundown: Danaher (NYSE:DHR) Vs Other Research Tools & Consumables Stocks - Finviz
Danaher Corporation Rated Third Best Investment During Recession, 2025 EPS Expected Between $7.70 and $7.80 - Intellectia AI
Danaher Corp.: The Quiet Machine Powering the Future of Diagnostics, Life Science and Industrial Tec - AD HOC NEWS
Leerink Partners Issues Positive Forecast for Danaher (NYSE:DHR) Stock Price - MarketBeat
Pinnacle Financial Partners Inc Decreases Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by Concurrent Investment Advisors LLC - MarketBeat
Danaher Corporation $DHR Shares Purchased by ASR Vermogensbeheer N.V. - MarketBeat
Is Danaher Corp Gaining or Losing Market Support? - Benzinga
Dillon & Associates Inc. Purchases 6,572 Shares of Danaher Corporation $DHR - MarketBeat
Generali Powszechne Towarzystwo Emerytalne Invests $18.04 Million in Danaher Corporation $DHR - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Grows Stock Position in Danaher Corporation $DHR - MarketBeat
Campbell & CO Investment Adviser LLC Buys Shares of 19,053 Danaher Corporation $DHR - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Danaher Corporation (DHR) And Encourages Investors to Connect - ACCESS Newswire
How Investors Are Reacting To Danaher (DHR) Upbeat 2025 Outlook And Growing Synthetic Biology Ambitions - Yahoo Finance
JPM26: Danaher positioned to improve patient diagnostics - Yahoo Finance
Danaher Corporation $DHR is Pacific Capital Partners Ltd's 6th Largest Position - MarketBeat
Danaher (DHR) Rebounded on Accelerated Demand - Yahoo Finance
Robeco Schweiz AG Has $56.81 Million Stake in Danaher Corporation $DHR - MarketBeat
Arcadia Investment Management Corp MI Cuts Position in Danaher Corporation $DHR - MarketBeat
2026-01-13 | Bronstein, Gewirtz & Grossman, LLC Encourages Danaher Corporation (DHR) Stockholders to Inquire about Securities Investigation | NYSE:DHR | Press Release - Stockhouse
Nordea Investment Management AB Grows Stake in Danaher Corporation $DHR - MarketBeat
MGO One Seven LLC Has $4.31 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corp. Co-Founder Mitch Rales, Northpond Ventures Lead $43M Round for VieCure - citybiz
Mar Vista U.S. Quality Q4 2025 Top Contributors And Detractors - Seeking Alpha
Danaher’s Biopharma Boom: Why 2026 Could Be A Game-Changer! - Smartkarma
Danaher Forecasts 4Q Revenue at High-End of Guidance on Bioprocessing Strength -- Update - marketscreener.com
How To YieldBoost Danaher To 4.5% Using Options - Nasdaq
Danaher Corp Azioni (DHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.50%
0.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):